Objective Sleep problems is the most common side effect of methylphenidate (MPH)
treatment in ADHD youth and carry potential to negatively impact long-term self-regulatory …

Objective: Short-term RCTs have demonstrated that MPH-treatment significantly reduces
ADHD-symptoms, but is also associated with adverse events, including sleep problems …

Methylphenidate (MPH) improves behavioral symptoms of attention-deficit/hyperactivity
disorder (ADHD). Its effects on sleep, however, are insufficiently known, as trials with MPH in …

Individual responses to methylphenidate (MPH) can significantly differ in children with
attention-deficit/hyperactivity disorder (ADHD) in terms of the extent of clinical amelioration …

Background: There are no objective, biological markers that can robustly predict
methylphenidate response in attention deficit hyperactivity disorder. This study aimed to …

Methylphenidate (MPH) is the treatment of first choice for developmental ADHD. To date, no
reliable method to predict how patients will respond to MPH exists and conflicting results are …

Abstract Background Attention Deficit Hyperactivity Disorder (ADHD) is one of the most
prevalent mental disorders of childhood, which often continues into adulthood …

Background Attention-deficit hyperactivity disorder (ADHD) is associated with disrupted
sleep and circadian rhythm. Medication for ADHD may have side effects aggravating sleep …

Objective The primary aim of this study was to investigate the acute impact of
methylphenidate (MPH) on sleep parameters in attention-deficit/hyperactivity disorder …

Purpose Methylphenidate (MPH), the first-line medication in children with attention-
deficit/hyperactivity disorder (ADHD), is associated with increased risk of sleep disorders …